Eurofins Scientific (EUFI.PA), a world leader in providing analytical support to the global pharmaceutical industry, announces that it has signed an agreement to acquire DiscoverX, a leader in drug discovery products and services across all stages of discovery from target identification and lead discovery to preclinical and beyond. The transaction is expected to close in […]
CAMBRIDGE, UK – Population Genetics Technologies Ltd (PGT) has exclusively licensed patent rights including US 8,481,292 covering its proprietary mutation verification tagging technology to Agilent Technologies. PGT retains exclusive rights to develop and commercialize mutation verification tagging for applications in human infectious disease diagnostics, and non-exclusive rights for veterinary diagnostics and plant genomic uses. Mutation […]
Molecular and Sample Barcoding IP Portfolio Bolsters Agilent’s Leadership Position in NGS Target Enrichment Solutions IP Portfolio Aimed at Improving Accuracy and Sensitivity of NGS Detection SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) (“Agilent”) today announced that it has acquired the molecular and sample barcoding patent portfolios of Population Genetics Technologies (“Population Genetics”). Founded […]
THOUSAND OAKS, Calif. – Teledyne Technologies Incorporated (NYSE:TDY) announced today that its subsidiary, Teledyne Instruments, Inc., has completed the acquisition of assets of Scientific Systems, Inc. (SSI). Headquartered in State College, Pa., SSI manufactures precision components and specialized subassemblies used primarily in analytical and diagnostic instrumentation, such as High Performance Liquid Chromatography (HPLC) systems and […]
Los Angeles, CA – StoneCalibre is pleased to announce that one of its affiliates has completed the acquisition of Alpha-Tec Systems, Inc., a Vancouver, WA based provider of in-vitro diagnostic products utilized by clinical laboratories in the disciplines of mycobacteriology, parasitology, bacteriology and mycology. “We are pleased to welcome Alpha-Tec to the StoneCalibre family,” said Brian […]
LGC announced today that it has acquired LINK Technologies, a premier supplier of speciality reagents for oligonucleotide synthesis. LINK’s products are used by oligonucleotide synthesis companies, university and commercial research departments as well as contract manufacturing organisations in the biotech sector. Following the acquisition, LGC will combine its Biosearch oligonucleotide reagent group, its Prime Synthesis CPG […]
Judges Scientific announces that its majority owned subsidiary Bordeaux Acquisition Limited (“Bordeaux”) has today acquired Oxford Cryosystems Ltd, the global leader in cryogenic devices for X-ray crystallography research. Oxford Cryosystems specialises in the design and manufacture of devices used to cryogenically cool crystalline samples during X-ray crystallography experiments, allowing users to investigate the structure of […]
New York – Arsenal Capital Partners (“Arsenal”) today announced that it has agreed to sell its portfolio company, Certara (the “Company”), the leading provider of technology-driven decision support solutions for drug development, to EQT VII Fund for an enterprise value of $850 million. As part of the transaction, Arsenal Capital Partners will retain a minority ownership […]
Linkage Biosciences joins Thermo Fisher Scientific’s Transplant Diagnostics business, which now represents both the One Lambda™ and Linkage Biosciences brands. We are united in our core belief that improving the lives of transplant patients worldwide is our ultimate objective. For our HLA and Transplant customers, we remain firmly committed to bringing you quality reagents and […]
EQT VII acquires Certara, the global leader in model-informed (in silico) drug development and regulatory science, focused on optimizing drug development and improving health outcomes Certara’s solutions help to inform and accelerate drug development and regulatory approval processes, while addressing the key efficacy, safety, productivity and commercial challenges facing the biopharma industry EQT VII to […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
